Catalyst Wire Dossier Catalyst Wire Dossier

AAVrh10-h.SGSH gene therapy

AAVrh10-h.SGSH · LYSOGENE
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAVrh10-h.SGSH gene therapy, covering 2021-08-31 to 2021-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA) [Phase 2, Phase 3]

See pricing